Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine + dexmedetomidine versus ketamine + dexmedetomidine for deep sedation during cystoscopy and ureteroscopy
IRCT20130304012695N24Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diphenhydramine, dexmedetomidine, ketamine and propofol (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Patient sedation level, Patient analgesia level and 5 more. Started Oct 2026; status: recruiting.
02
Drugs
diphenhydraminedexmedetomidineketaminepropofol
Beyond the preview
Go deeper on IRCT20130304012695N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N24.